Evolving Impact of COVID-19 on Transplant Center Practices and Policies in the United States.

Boyarsky, Brian J; Ruck, Jessica M; Chiang, Teresa Po-Yu; Werbel, William A; Strauss, Alexandra T; Getsin, Samantha N; Jackson, Kyle R; Kernodle, Amber B; Van Pilsum Rasmussen, Sarah E; Baker, Talia B; Al Ammary, Fawaz; Durand, Christine M; Avery, Robin K; Massie, Allan B; Segev, Dorry L; Garonzik-Wang, Jacqueline M

In our first survey of transplant centers in March 2020, >75% of kidney and liver programs were either suspended or operating under restrictions. To safely resume transplantation, we must understand the evolving impact of COVID-19 on transplant recipients and center-level practices. We therefore conducted a six-week follow-up survey May 7-15, 2020 and linked responses to the COVID-19 incidence map, with a response rate of 84%. Suspension of live donor transplantation decreased from 72% in March to 30% in May for kidneys and from 68% to 52% for livers. Restrictions/suspension of deceased donor transplantation decreased from 84% to 58% for kidneys and from 73% to 42% for livers. Resuming transplantation at normal capacity was envisioned by 83% of programs by August 2020. Exclusively using local recovery teams for deceased donor procurement was reported by 28%. Respondents reported caring for a total of 1,166 COVID-19-positive transplant recipients; 25% were critically ill. Telemedicine challenges were reported by 81%. There was a lack of consensus regarding management of potential living donors or candidates with SARS-CoV-2. Our findings demonstrate persistent heterogeneity in center-level response to COVID-19 even as transplant activity resumes, making ongoing national data collection and real-time analysis critical to inform best practices.